Allmed Solutions (XTAE:ALMD) Long-Term Debt: ₪0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTAE:ALMD Allmed Solutions Ltd XTAE:ALMD
29 GF Score
Price ₪0.33
! 3 Warning Signs
View Full Analysis

What is Allmed Solutions Long-Term Debt?

Allmed Solutions XTAE:ALMD 29 Long-Term Debt is ₪0.00 Mil as of Dec. 2025. GuruFocus rates XTAE:ALMD with a GF Score™ of 29/100. The stock has 3 warning signs investors should review.

Allmed Solutions's Long-Term Debt for the quarter that ended in Dec. 2025 was ₪0.00 Mil.

Allmed Solutions  (XTAE:ALMD) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Allmed Solutions Long-Term Debt Related Terms

Allmed Solutions Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Allmed Solutions's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Allmed Solutions Long-Term Debt Chart

Allmed Solutions Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Allmed Solutions Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XTAE:ALMD
29GF Score
Allmed Solutions Ltd XTAE:ALMD
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of ₪0.00 Mil mean?
Allmed Solutions (XTAE:ALMD) has a Long-Term Debt of ₪0.00 Mil as of Dec. 2025.
Is Allmed Solutions' Long-Term Debt too high?
Allmed Solutions' current Long-Term Debt is ₪0.00 Mil. Overall, Allmed Solutions has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Allmed Solutions' Long-Term Debt compare to ABT and SYK?
Allmed Solutions' Long-Term Debt of ₪0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Devices & Instruments company?
A good Long-Term Debt depends on the Medical Devices & Instruments industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Allmed Solutions's current Long-Term Debt is ₪0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Allmed Solutions stock overvalued right now?
Allmed Solutions (XTAE:ALMD) has a current Long-Term Debt of ₪0.00 Mil. The current Long-Term Debt is ₪0.00 Mil. Allmed Solutions' overall GF Score™ is 29/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Allmed Solutions (XTAE:ALMD), the current Long-Term Debt is ₪0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Allmed Solutions Business Description

Address 2 Ha-Eshel Street, P.O.BOX 3081, Caesarea Industrial Park, Caesarea, ISR, 3079501
Allmed Solutions Ltd develops, manufactures and markets minimally invasive products internationally in various medical disciplines.
29GF Score

Get the complete analysis for XTAE:ALMD

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₪0.33
Price